Without adequate reporting and
early surveillance of illness trends after vaccinations, it takes longer to detect and respond to a vaccine issue. One Harvard medical study indi-
cated VAERS may understate vaccine- associated health issues by over 800%. “The system is not a good system,
and people have known that for many, many years,” says Robert F. Kennedy Jr., the iconoclastic vaccine skeptic and independent presidential candi- date, in a September appearance on C-Span’s Washington Journal. “If for example you receive the vac-
cine and die 17 days later, your doctor then needs to report that to VAERS and say, ‘This is a possible vaccine death.’ “Most doctors aren’t going to do
Seasonal Flu Still a Killer
T
he flu kills tens of thousands of U.S. residents every year. In fact,
in some years more Americans die from flu than automobile accidents.
ANNUAL FLU DEATHS Year
2012 2013 2014 2015 2016 2017 2018 2019 2020
SOURCE:
Statista.com *CDC estimates
ANNUAL ROAD DEATHS Year
2012 2013 2014 2015 2016 2017 2018 2019 2020
Source:
Statista.com
Deaths* 12,000 43,000 38,000 51,000 23,000 38,000 52,000 28,000 25,000
Deaths 36,415 35,369 35,398 37,757 40,327 40,231 39,404 39,107 42,339
A new vaccine is typically only tested on a few thousand people during clinical trials. That is just a tiny fraction of the millions of recipients who will ultimately receive the vaccine.
that because they don’t see the con- nection.”
Kennedy favors a machine-count-
ing method that correlates a patient’s vaccine records with their subsequent examinations and treatments based on records amassed by HMOs and health insurance companies. Researchers at Harvard spent
three years developing and testing a machine-counting system to tabulate possible reactions after Harvard Pil- grim HMO patients received vaccines — and the result was remarkable. Their study determined the
VAERS system was hugely under- counting possible adverse reactions. Yet the researchers said federal health bureaucrats refused to even discuss their findings. Dr. Peter Hibberd, a member of
the American College of Emergency Physicians and a fellow of the Ameri- can Board of Emergency Medicine, tells Newsmax that the CDC and FDA weren’t prepared to manage the flood of data that the new reporting system would have generated based on their study, which ran from 2006 to 2009. “The Harvard machine-counting
system is probably the only one that should be relied upon,” Hibberd says. “But that was thrown out because it was generating too much data. They didn’t have the resources then, but now we’ve got Artificial Intelligence.” VAERS opponents are raising
the issue again because of the cur- rent debate over the mRNA COVID- 19 vaccine. There have been rare but statistically relevant reports of heart inflammation and anaphylaxis in a small fraction of patients. Several less serious side effects have been reported as well.
Of course, all drugs and vaccines
are subject to clinical trials to estab- lish their safety prior to approval for distribution to the general public. But Hibberd is skeptical those trials are adequate. “Anyone that wants to listen to pri-
vate industry and have you tell them how good and effective their drug is,” Hibberd says, “you have to know that the bad stuff doesn’t have to be reported. “All kinds of errors were and are
built into drug companies’ trials. Drug company trials have never been reliable.” A new vaccine is typically only test-
ed on a few thousand people during clinical trials. That is just a tiny frac- tion of the millions of recipients who will ultimately receive the vaccine. As more and more people receive
a vaccination, rare but serious side effects may emerge. In 1997, VAERS data alerted doc-
tors that eight to 10 instances of vaccine-induced paralysis stemming from the childhood polio vaccine were occurring annually. Based on that information, officials adjusted the vac- cine schedule and adverse reactions dropped markedly. Clinical trials, similarly, detected
no issues with the 1998 vaccine target- ing rotavirus, an illness that causes severe, potentially life-threatening diarrhea in infants and children. But after the vaccine was intro-
duced, researchers determined that within a week of receiving their first dose of the vaccine, one child in 5,000 to 10,000 would develop a severe bowl obstruction. That vaccine was pulled off the mar-
ket, and it took nine years for a safer rotavirus vaccine to be introduced.
DECEMBER 2023 | NEWSMAX 25
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108